Cutera, a provider of laser and other light-based aesthetic systems for practitioners, has announced regulatory clearance and the commencement of shipments for its Pearl Fractional device.
Subscribe to our email newsletter
The company said that it will begin sales and marketing activities in the US, Europe and Australia. Pearl Fractional, with its proprietary 2,790nm wavelength, is the company’s solution for the fractional ablative market, said Cutera.
Kevin Connors, president and CEO of Cutera, said: Pearl Fractional targets the deep dermis to treat the signs of aging. Our team recognized the limitations of CO2 fractional lasers and designed our product to deliver a better experience to patients and physicians. Pearl Fractional produces a confined thermal zone in the dermis with the goal of reducing post-operative downtime, which we believe will result in greater patient interest.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.